Corporate & Finance Group advised Clinipace Worldwide on its 100% acquisition of Choice Pharma (HK)
2014.02.24.
Yulchon"s Corporate & Finance Group advised Clinipace Worldwide, a contract research organization based in the United States, in connection with its acquisition of Choice Pharma (HK) Limited, a clinical research company with subsidiaries or representative offices in countries such as Korea, China, Taiwan, Singapore and Vietnam. Yulchon advised Clinipace Worldwide with respect to the issues pertaining to the Korean subsidiary and the Vietnamese representative office, including performing legal due diligence, concluding the share purchase agreement and executing the closing on the transaction.
Ki Young Kim, Yong Geun Bae, Su Gu Kang and Hyun Jeong Kim on the transaction.
.JPEG)
